AVECRIS

Singapore, Singapore

AVECRIS is addressing one of gene therapy's most difficult challenges: long-lasting, cell-type-specific expression.

$5K raised

Aug 2022

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AVECRIS raised?

AVECRIS has raised $5K in total funding. The most recent round was Grant. The last funding was announced in August 2022.

Who are AVECRIS's investors?

AVECRIS's investors include First Flight Venture Center, Alameda Research.

Where is AVECRIS headquartered?

AVECRIS is headquartered in Singapore, Singapore.

What does AVECRIS do?

AVECRIS is addressing one of gene therapy's most difficult challenges: long-lasting, cell-type-specific expression.

What stage is AVECRIS at?

AVECRIS is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 10, 2022.

MLA

"AVECRIS — Funding & Investors." VCBacked, August 10, 2022, https://www.vcbacked.co/company/avecris. Accessed July 2, 2026.

APA

VCBacked. (2022). AVECRIS — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/avecris

Wikipedia (cite web)

{{cite web |title=AVECRIS — Funding & Investors |url=https://www.vcbacked.co/company/avecris |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 10, 2022.